trar  (Worthington Biochemical)


Bioz Verified Symbol Worthington Biochemical is a verified supplier
Bioz Manufacturer Symbol Worthington Biochemical manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
    Name:
    Deoxyribonuclease I
    Description:
    Chromatographically purified A lyophilized powder with glycine as a stabilizer
    Catalog Number:
    ls002004
    Price:
    33
    Size:
    5 mg
    Source:
    Bovine Pancreas
    Cas Number:
    9003.98.9
    		Buy from Supplier

    Structured Review

    Worthington Biochemical trar
    Models for <t>TraR</t> and the TraR–RNAP complex. ( A ) RaptorX-derived model for TraR. N- and C-termini are indicated, the four cysteine residues (C4) are tan spheres, and residues D3, D6, A8, I20, and E66 are in blue stick form. ( B ) TraR (blue) and <t>DksA</t> (green) were positioned manually based on alignment of TraR D3, D6, and A8 with DksA D71, D74, and A76, a portion of the TraR N-terminal α-helix, and the DksA α-helix 2 in its coiled-coil. Cysteines (C4) are yellow or tan spheres. ( C ) Model for TraR binding to E. coli ). The square corresponds to the area of the complex shown in expanded form in D and E . TraR is dark blue; the RNAP β-subunit is cyan, β′ is pink, the β′ secondary channel rim is yellow, and ω is pale blue. β′ Residues N680, K681A, and E677 are shown as orange spheres. ppGpp at site 1 is shown in red. TraR residues D3, D6, I44, A47, R48, I51, A47, and E66 are shown as blue spheres. ( D ) Enlarged view of TraR bound to RNAP secondary channel, as in C . I20 is in stick form. BH, bridge helix. ( E .
    Chromatographically purified A lyophilized powder with glycine as a stabilizer
    https://www.bioz.com/result/trar/product/Worthington Biochemical
    Average 90 stars, based on 601 article reviews
    Price from $9.99 to $1999.99
    trar - by Bioz Stars, 2021-01
    90/100 stars

    Related Products / Commonly Used Together

    mgcl2
    nacl
    kcl
    pbs
    tris-hcl
    dntp
    dntps
    dtt
    hepes
    taq dna polymerase
    edta
    tris
    triton x-100
    rna
    cacl2

    Images

    1) Product Images from "TraR directly regulates transcription initiation by mimicking the combined effects of the global regulators DksA and ppGpp"

    Article Title: TraR directly regulates transcription initiation by mimicking the combined effects of the global regulators DksA and ppGpp

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    doi: 10.1073/pnas.1704105114

    Models for TraR and the TraR–RNAP complex. ( A ) RaptorX-derived model for TraR. N- and C-termini are indicated, the four cysteine residues (C4) are tan spheres, and residues D3, D6, A8, I20, and E66 are in blue stick form. ( B ) TraR (blue) and DksA (green) were positioned manually based on alignment of TraR D3, D6, and A8 with DksA D71, D74, and A76, a portion of the TraR N-terminal α-helix, and the DksA α-helix 2 in its coiled-coil. Cysteines (C4) are yellow or tan spheres. ( C ) Model for TraR binding to E. coli ). The square corresponds to the area of the complex shown in expanded form in D and E . TraR is dark blue; the RNAP β-subunit is cyan, β′ is pink, the β′ secondary channel rim is yellow, and ω is pale blue. β′ Residues N680, K681A, and E677 are shown as orange spheres. ppGpp at site 1 is shown in red. TraR residues D3, D6, I44, A47, R48, I51, A47, and E66 are shown as blue spheres. ( D ) Enlarged view of TraR bound to RNAP secondary channel, as in C . I20 is in stick form. BH, bridge helix. ( E .
    Figure Legend Snippet: Models for TraR and the TraR–RNAP complex. ( A ) RaptorX-derived model for TraR. N- and C-termini are indicated, the four cysteine residues (C4) are tan spheres, and residues D3, D6, A8, I20, and E66 are in blue stick form. ( B ) TraR (blue) and DksA (green) were positioned manually based on alignment of TraR D3, D6, and A8 with DksA D71, D74, and A76, a portion of the TraR N-terminal α-helix, and the DksA α-helix 2 in its coiled-coil. Cysteines (C4) are yellow or tan spheres. ( C ) Model for TraR binding to E. coli ). The square corresponds to the area of the complex shown in expanded form in D and E . TraR is dark blue; the RNAP β-subunit is cyan, β′ is pink, the β′ secondary channel rim is yellow, and ω is pale blue. β′ Residues N680, K681A, and E677 are shown as orange spheres. ppGpp at site 1 is shown in red. TraR residues D3, D6, I44, A47, R48, I51, A47, and E66 are shown as blue spheres. ( D ) Enlarged view of TraR bound to RNAP secondary channel, as in C . I20 is in stick form. BH, bridge helix. ( E .

    Techniques Used: Derivative Assay, Binding Assay

    ( A ) Activation of p hisG , p livJ , or RNA-1 by TraR (0–500 nM). ( B ) Activation shown reflects maximum activation observed. Transcription of iraP P1 is activated to a different extent by TraR vs. DksA/ppGpp. Values plotted with TraR (1 µM), DksA (1 µM), or DksA (2 µM) and ppGpp (50 µM) together, relative to transcription without factors (set to 1).
    Figure Legend Snippet: ( A ) Activation of p hisG , p livJ , or RNA-1 by TraR (0–500 nM). ( B ) Activation shown reflects maximum activation observed. Transcription of iraP P1 is activated to a different extent by TraR vs. DksA/ppGpp. Values plotted with TraR (1 µM), DksA (1 µM), or DksA (2 µM) and ppGpp (50 µM) together, relative to transcription without factors (set to 1).

    Techniques Used: Activation Assay

    A half-DksA variant, similar in length to WT TraR, does not complement a ∆ dksA mutant. ( A ) Representative Western blot from cell lysates made from a ∆ dksA strain carrying either the WT gene or the half - dksA gene fused to an IPTG-inducible promoter. Cells were harvested 1, 2, or 3 h after induction with 0.5 mM IPTG. One-microgram of cell lysate was loaded in each lane, and purified DksA-HMK was loaded in lane 1 for comparison. Somewhat lower amounts of the half-DksA variant were observed than of WT DksA, which could be attributable to lower stability of the half-DksA variant or to reduced ability of the DksA antibody to recognize the half-DksA peptide. ( B and C ) Growth on plates containing defined medium without amino acids and ( B ) 0.1 mM IPTG or ( C ) 1 mM IPTG. Sector 1: empty vector control. Sector 2: plasmid containing half - dksA gene. Sector 3: plasmid containing the full-length traR gene. Sector 4: plasmid containing the full-length dksA gene. Even if the half-DksA concentration was lower than the WT DksA concentration, it is likely that the half-DksA would have still resulted in at least partial complementation, because we showed previously that even 50% of the WT concentration supplied from a plasmid was sufficient to complement a ∆ dksA ).
    Figure Legend Snippet: A half-DksA variant, similar in length to WT TraR, does not complement a ∆ dksA mutant. ( A ) Representative Western blot from cell lysates made from a ∆ dksA strain carrying either the WT gene or the half - dksA gene fused to an IPTG-inducible promoter. Cells were harvested 1, 2, or 3 h after induction with 0.5 mM IPTG. One-microgram of cell lysate was loaded in each lane, and purified DksA-HMK was loaded in lane 1 for comparison. Somewhat lower amounts of the half-DksA variant were observed than of WT DksA, which could be attributable to lower stability of the half-DksA variant or to reduced ability of the DksA antibody to recognize the half-DksA peptide. ( B and C ) Growth on plates containing defined medium without amino acids and ( B ) 0.1 mM IPTG or ( C ) 1 mM IPTG. Sector 1: empty vector control. Sector 2: plasmid containing half - dksA gene. Sector 3: plasmid containing the full-length traR gene. Sector 4: plasmid containing the full-length dksA gene. Even if the half-DksA concentration was lower than the WT DksA concentration, it is likely that the half-DksA would have still resulted in at least partial complementation, because we showed previously that even 50% of the WT concentration supplied from a plasmid was sufficient to complement a ∆ dksA ).

    Techniques Used: Variant Assay, Mutagenesis, Western Blot, Purification, Plasmid Preparation, Concentration Assay

    TraR is more active than DksA for inhibition of transcription but has a similar affinity for RNAP. ( A ) Multiround in vitro transcription of rrnB P1 or lacUV 5 at a range of concentrations of TraR (wedge indicates 1 nM to 1 µM for rrnB P1 or 1 nM to 2 µM for lacUV5 ) or of DksA (wedge indicates 4 nM to 8 µM). Plasmid templates also contained the RNA-1 promoter. ( B ) Quantification of transcripts from experiments like those in A plotted relative to values in the absence of TraR or DksA. The IC 50 for inhibition by TraR was ∼50 nM and for DksA ∼1.3 µM [averages with SDs from at least three independent experiments ( n = 3)]. ( C ) Cross-linking with β′ R933-Bpa RNAP, β′ Q929-Bpa RNAP, or β′ R1148-Bpa RNAP with 32 P-TraR or 32 P-DksA. The portion of a representative 4–12% SDS gel containing the cross-linked β′-DksA or β′-TraR products is shown. ( D ) Unlabeled DksA or TraR competes similarly for binding of 32 P-labeled HMK-DksA to RNAP. Unlabeled DksA or TraR (0–16 µM) was added to 1 µM 32 P-DksA and 0.1 µM core RNAP before Fe 2+ -mediated cleavage of DksA. Fraction of 32 P-DksA cleaved was normalized to that in the absence of competitor. Next, 1 µM unlabeled DksA or 0.6 µM unlabeled TraR reduced cleavage of 1 µM 32 P-DksA by ∼50% ( n = 3). ( E ) Representative gel showing DNase I footprints of RNAP bound to the rrnB P1 promoter, 3′ end-labeled on the template strand, with or without TraR or DksA. DNase I digested fragment without RNAP or added factors (lanes 1 and 2), with RNAP alone (lanes 3 and 4), with RNAP + 5 µM DksA (lanes 5 and 6), or with RNAP and 5 µM TraR (lanes 7 and 8). Undigested fragment (lane 9). A+G sequence ladder is on the Left . Traces of gel lanes showing extent of protection are on the Right . Colored dots indicate the downstream boundary of DNase I protection without (green dot; ∼+12), or with (red or blue dots; ∼+1) DksA or TraR. The upstream boundary of protection in lanes 3–8 is ∼−59 ( n = 3). ( F ) TraR and DksA alter the lifetime of rrnB P1(dis) promoter complexes in vitro. RNAP–promoter complexes were preformed with TraR (15 nM) or DksA (15 nM or 500 nM), or without factors, and the fraction remaining at the indicated times after heparin addition was determined by transcription. Half-lives of rrnB P1(dis) complexes: no added factor, 18 min; 15 nM TraR, 3 min; 15 nM DksA, 18 min; 500 nM DksA, 6 min. Error bars indicate the range from two independent experiments ( n = 2).
    Figure Legend Snippet: TraR is more active than DksA for inhibition of transcription but has a similar affinity for RNAP. ( A ) Multiround in vitro transcription of rrnB P1 or lacUV 5 at a range of concentrations of TraR (wedge indicates 1 nM to 1 µM for rrnB P1 or 1 nM to 2 µM for lacUV5 ) or of DksA (wedge indicates 4 nM to 8 µM). Plasmid templates also contained the RNA-1 promoter. ( B ) Quantification of transcripts from experiments like those in A plotted relative to values in the absence of TraR or DksA. The IC 50 for inhibition by TraR was ∼50 nM and for DksA ∼1.3 µM [averages with SDs from at least three independent experiments ( n = 3)]. ( C ) Cross-linking with β′ R933-Bpa RNAP, β′ Q929-Bpa RNAP, or β′ R1148-Bpa RNAP with 32 P-TraR or 32 P-DksA. The portion of a representative 4–12% SDS gel containing the cross-linked β′-DksA or β′-TraR products is shown. ( D ) Unlabeled DksA or TraR competes similarly for binding of 32 P-labeled HMK-DksA to RNAP. Unlabeled DksA or TraR (0–16 µM) was added to 1 µM 32 P-DksA and 0.1 µM core RNAP before Fe 2+ -mediated cleavage of DksA. Fraction of 32 P-DksA cleaved was normalized to that in the absence of competitor. Next, 1 µM unlabeled DksA or 0.6 µM unlabeled TraR reduced cleavage of 1 µM 32 P-DksA by ∼50% ( n = 3). ( E ) Representative gel showing DNase I footprints of RNAP bound to the rrnB P1 promoter, 3′ end-labeled on the template strand, with or without TraR or DksA. DNase I digested fragment without RNAP or added factors (lanes 1 and 2), with RNAP alone (lanes 3 and 4), with RNAP + 5 µM DksA (lanes 5 and 6), or with RNAP and 5 µM TraR (lanes 7 and 8). Undigested fragment (lane 9). A+G sequence ladder is on the Left . Traces of gel lanes showing extent of protection are on the Right . Colored dots indicate the downstream boundary of DNase I protection without (green dot; ∼+12), or with (red or blue dots; ∼+1) DksA or TraR. The upstream boundary of protection in lanes 3–8 is ∼−59 ( n = 3). ( F ) TraR and DksA alter the lifetime of rrnB P1(dis) promoter complexes in vitro. RNAP–promoter complexes were preformed with TraR (15 nM) or DksA (15 nM or 500 nM), or without factors, and the fraction remaining at the indicated times after heparin addition was determined by transcription. Half-lives of rrnB P1(dis) complexes: no added factor, 18 min; 15 nM TraR, 3 min; 15 nM DksA, 18 min; 500 nM DksA, 6 min. Error bars indicate the range from two independent experiments ( n = 2).

    Techniques Used: Inhibition, In Vitro, Plasmid Preparation, SDS-Gel, Binding Assay, Labeling, Sequencing

    2) Product Images from "TraR directly regulates transcription initiation by mimicking the combined effects of the global regulators DksA and ppGpp"

    Article Title: TraR directly regulates transcription initiation by mimicking the combined effects of the global regulators DksA and ppGpp

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    doi: 10.1073/pnas.1704105114

    Models for TraR and the TraR–RNAP complex. ( A ) RaptorX-derived model for TraR. N- and C-termini are indicated, the four cysteine residues (C4) are tan spheres, and residues D3, D6, A8, I20, and E66 are in blue stick form. ( B ) TraR (blue) and DksA (green) were positioned manually based on alignment of TraR D3, D6, and A8 with DksA D71, D74, and A76, a portion of the TraR N-terminal α-helix, and the DksA α-helix 2 in its coiled-coil. Cysteines (C4) are yellow or tan spheres. ( C ) Model for TraR binding to E. coli ). The square corresponds to the area of the complex shown in expanded form in D and E . TraR is dark blue; the RNAP β-subunit is cyan, β′ is pink, the β′ secondary channel rim is yellow, and ω is pale blue. β′ Residues N680, K681A, and E677 are shown as orange spheres. ppGpp at site 1 is shown in red. TraR residues D3, D6, I44, A47, R48, I51, A47, and E66 are shown as blue spheres. ( D ) Enlarged view of TraR bound to RNAP secondary channel, as in C . I20 is in stick form. BH, bridge helix. ( E .
    Figure Legend Snippet: Models for TraR and the TraR–RNAP complex. ( A ) RaptorX-derived model for TraR. N- and C-termini are indicated, the four cysteine residues (C4) are tan spheres, and residues D3, D6, A8, I20, and E66 are in blue stick form. ( B ) TraR (blue) and DksA (green) were positioned manually based on alignment of TraR D3, D6, and A8 with DksA D71, D74, and A76, a portion of the TraR N-terminal α-helix, and the DksA α-helix 2 in its coiled-coil. Cysteines (C4) are yellow or tan spheres. ( C ) Model for TraR binding to E. coli ). The square corresponds to the area of the complex shown in expanded form in D and E . TraR is dark blue; the RNAP β-subunit is cyan, β′ is pink, the β′ secondary channel rim is yellow, and ω is pale blue. β′ Residues N680, K681A, and E677 are shown as orange spheres. ppGpp at site 1 is shown in red. TraR residues D3, D6, I44, A47, R48, I51, A47, and E66 are shown as blue spheres. ( D ) Enlarged view of TraR bound to RNAP secondary channel, as in C . I20 is in stick form. BH, bridge helix. ( E .

    Techniques Used: Derivative Assay, Binding Assay

    ( A ) Activation of p hisG , p livJ , or RNA-1 by TraR (0–500 nM). ( B ) Activation shown reflects maximum activation observed. Transcription of iraP P1 is activated to a different extent by TraR vs. DksA/ppGpp. Values plotted with TraR (1 µM), DksA (1 µM), or DksA (2 µM) and ppGpp (50 µM) together, relative to transcription without factors (set to 1).
    Figure Legend Snippet: ( A ) Activation of p hisG , p livJ , or RNA-1 by TraR (0–500 nM). ( B ) Activation shown reflects maximum activation observed. Transcription of iraP P1 is activated to a different extent by TraR vs. DksA/ppGpp. Values plotted with TraR (1 µM), DksA (1 µM), or DksA (2 µM) and ppGpp (50 µM) together, relative to transcription without factors (set to 1).

    Techniques Used: Activation Assay

    A half-DksA variant, similar in length to WT TraR, does not complement a ∆ dksA mutant. ( A ) Representative Western blot from cell lysates made from a ∆ dksA strain carrying either the WT gene or the half - dksA gene fused to an IPTG-inducible promoter. Cells were harvested 1, 2, or 3 h after induction with 0.5 mM IPTG. One-microgram of cell lysate was loaded in each lane, and purified DksA-HMK was loaded in lane 1 for comparison. Somewhat lower amounts of the half-DksA variant were observed than of WT DksA, which could be attributable to lower stability of the half-DksA variant or to reduced ability of the DksA antibody to recognize the half-DksA peptide. ( B and C ) Growth on plates containing defined medium without amino acids and ( B ) 0.1 mM IPTG or ( C ) 1 mM IPTG. Sector 1: empty vector control. Sector 2: plasmid containing half - dksA gene. Sector 3: plasmid containing the full-length traR gene. Sector 4: plasmid containing the full-length dksA gene. Even if the half-DksA concentration was lower than the WT DksA concentration, it is likely that the half-DksA would have still resulted in at least partial complementation, because we showed previously that even 50% of the WT concentration supplied from a plasmid was sufficient to complement a ∆ dksA ).
    Figure Legend Snippet: A half-DksA variant, similar in length to WT TraR, does not complement a ∆ dksA mutant. ( A ) Representative Western blot from cell lysates made from a ∆ dksA strain carrying either the WT gene or the half - dksA gene fused to an IPTG-inducible promoter. Cells were harvested 1, 2, or 3 h after induction with 0.5 mM IPTG. One-microgram of cell lysate was loaded in each lane, and purified DksA-HMK was loaded in lane 1 for comparison. Somewhat lower amounts of the half-DksA variant were observed than of WT DksA, which could be attributable to lower stability of the half-DksA variant or to reduced ability of the DksA antibody to recognize the half-DksA peptide. ( B and C ) Growth on plates containing defined medium without amino acids and ( B ) 0.1 mM IPTG or ( C ) 1 mM IPTG. Sector 1: empty vector control. Sector 2: plasmid containing half - dksA gene. Sector 3: plasmid containing the full-length traR gene. Sector 4: plasmid containing the full-length dksA gene. Even if the half-DksA concentration was lower than the WT DksA concentration, it is likely that the half-DksA would have still resulted in at least partial complementation, because we showed previously that even 50% of the WT concentration supplied from a plasmid was sufficient to complement a ∆ dksA ).

    Techniques Used: Variant Assay, Mutagenesis, Western Blot, Purification, Plasmid Preparation, Concentration Assay

    TraR is more active than DksA for inhibition of transcription but has a similar affinity for RNAP. ( A ) Multiround in vitro transcription of rrnB P1 or lacUV 5 at a range of concentrations of TraR (wedge indicates 1 nM to 1 µM for rrnB P1 or 1 nM to 2 µM for lacUV5 ) or of DksA (wedge indicates 4 nM to 8 µM). Plasmid templates also contained the RNA-1 promoter. ( B ) Quantification of transcripts from experiments like those in A plotted relative to values in the absence of TraR or DksA. The IC 50 for inhibition by TraR was ∼50 nM and for DksA ∼1.3 µM [averages with SDs from at least three independent experiments ( n = 3)]. ( C ) Cross-linking with β′ R933-Bpa RNAP, β′ Q929-Bpa RNAP, or β′ R1148-Bpa RNAP with 32 P-TraR or 32 P-DksA. The portion of a representative 4–12% SDS gel containing the cross-linked β′-DksA or β′-TraR products is shown. ( D ) Unlabeled DksA or TraR competes similarly for binding of 32 P-labeled HMK-DksA to RNAP. Unlabeled DksA or TraR (0–16 µM) was added to 1 µM 32 P-DksA and 0.1 µM core RNAP before Fe 2+ -mediated cleavage of DksA. Fraction of 32 P-DksA cleaved was normalized to that in the absence of competitor. Next, 1 µM unlabeled DksA or 0.6 µM unlabeled TraR reduced cleavage of 1 µM 32 P-DksA by ∼50% ( n = 3). ( E ) Representative gel showing DNase I footprints of RNAP bound to the rrnB P1 promoter, 3′ end-labeled on the template strand, with or without TraR or DksA. DNase I digested fragment without RNAP or added factors (lanes 1 and 2), with RNAP alone (lanes 3 and 4), with RNAP + 5 µM DksA (lanes 5 and 6), or with RNAP and 5 µM TraR (lanes 7 and 8). Undigested fragment (lane 9). A+G sequence ladder is on the Left . Traces of gel lanes showing extent of protection are on the Right . Colored dots indicate the downstream boundary of DNase I protection without (green dot; ∼+12), or with (red or blue dots; ∼+1) DksA or TraR. The upstream boundary of protection in lanes 3–8 is ∼−59 ( n = 3). ( F ) TraR and DksA alter the lifetime of rrnB P1(dis) promoter complexes in vitro. RNAP–promoter complexes were preformed with TraR (15 nM) or DksA (15 nM or 500 nM), or without factors, and the fraction remaining at the indicated times after heparin addition was determined by transcription. Half-lives of rrnB P1(dis) complexes: no added factor, 18 min; 15 nM TraR, 3 min; 15 nM DksA, 18 min; 500 nM DksA, 6 min. Error bars indicate the range from two independent experiments ( n = 2).
    Figure Legend Snippet: TraR is more active than DksA for inhibition of transcription but has a similar affinity for RNAP. ( A ) Multiround in vitro transcription of rrnB P1 or lacUV 5 at a range of concentrations of TraR (wedge indicates 1 nM to 1 µM for rrnB P1 or 1 nM to 2 µM for lacUV5 ) or of DksA (wedge indicates 4 nM to 8 µM). Plasmid templates also contained the RNA-1 promoter. ( B ) Quantification of transcripts from experiments like those in A plotted relative to values in the absence of TraR or DksA. The IC 50 for inhibition by TraR was ∼50 nM and for DksA ∼1.3 µM [averages with SDs from at least three independent experiments ( n = 3)]. ( C ) Cross-linking with β′ R933-Bpa RNAP, β′ Q929-Bpa RNAP, or β′ R1148-Bpa RNAP with 32 P-TraR or 32 P-DksA. The portion of a representative 4–12% SDS gel containing the cross-linked β′-DksA or β′-TraR products is shown. ( D ) Unlabeled DksA or TraR competes similarly for binding of 32 P-labeled HMK-DksA to RNAP. Unlabeled DksA or TraR (0–16 µM) was added to 1 µM 32 P-DksA and 0.1 µM core RNAP before Fe 2+ -mediated cleavage of DksA. Fraction of 32 P-DksA cleaved was normalized to that in the absence of competitor. Next, 1 µM unlabeled DksA or 0.6 µM unlabeled TraR reduced cleavage of 1 µM 32 P-DksA by ∼50% ( n = 3). ( E ) Representative gel showing DNase I footprints of RNAP bound to the rrnB P1 promoter, 3′ end-labeled on the template strand, with or without TraR or DksA. DNase I digested fragment without RNAP or added factors (lanes 1 and 2), with RNAP alone (lanes 3 and 4), with RNAP + 5 µM DksA (lanes 5 and 6), or with RNAP and 5 µM TraR (lanes 7 and 8). Undigested fragment (lane 9). A+G sequence ladder is on the Left . Traces of gel lanes showing extent of protection are on the Right . Colored dots indicate the downstream boundary of DNase I protection without (green dot; ∼+12), or with (red or blue dots; ∼+1) DksA or TraR. The upstream boundary of protection in lanes 3–8 is ∼−59 ( n = 3). ( F ) TraR and DksA alter the lifetime of rrnB P1(dis) promoter complexes in vitro. RNAP–promoter complexes were preformed with TraR (15 nM) or DksA (15 nM or 500 nM), or without factors, and the fraction remaining at the indicated times after heparin addition was determined by transcription. Half-lives of rrnB P1(dis) complexes: no added factor, 18 min; 15 nM TraR, 3 min; 15 nM DksA, 18 min; 500 nM DksA, 6 min. Error bars indicate the range from two independent experiments ( n = 2).

    Techniques Used: Inhibition, In Vitro, Plasmid Preparation, SDS-Gel, Binding Assay, Labeling, Sequencing

    3) Product Images from "A mutant RNA polymerase that forms unusual open promoter complexes"

    Article Title: A mutant RNA polymerase that forms unusual open promoter complexes

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    doi:

    The mutant RNAP promoter complexes are stable at low temperatures. ( A ) DNase I footprinting and KMnO 4 probing of promoter complexes at different temperatures (bottom strand). Promoter complexes were formed at the indicated temperatures and followed by DNase I and KMnO 4 treatment. ( B ) KMnO 4 probing of promoter complexes formed at −20°C in 50% glycerol to prevent freezing. The 37°C controls were conducted in the presence (lanes 4 and 6) or the absence (lanes 3 and 5) of 50% glycerol in the reaction buffer. The results indicate that open complex formation and KMnO 4 sensitivity were not affected by the glycerol. See Materials and Methods for experimental details. ( C ) Quantitative KMnO 4 probing of promoter complexes formed at different temperatures. Promoter complex formation reactions were set up on ice or 37°C, brought to the assay temperature, incubated for 15 min, and probed with KMnO 4 . The reaction products were separated by denaturing PAGE ( Top ) and quantified as described in Materials and Methods ( Bottom ). KMnO 4 probing was performed at 0 (lanes 1, 12, 13, and 24); 5 (lanes 2, 11, 14, and 23); 10 (lanes 3, 10, 15, and 22); 15 (lanes 4, 9, 16, and 21); 23 (lanes 5, 8, 17, and 20); and 37°C (lanes 6, 7, 18, and 19). The upward vertical arrows indicate an up-temperature shift from 0°C to the assay temperature; downward arrows indicate a down-temperature shift from 37°C to the assay temperature.
    Figure Legend Snippet: The mutant RNAP promoter complexes are stable at low temperatures. ( A ) DNase I footprinting and KMnO 4 probing of promoter complexes at different temperatures (bottom strand). Promoter complexes were formed at the indicated temperatures and followed by DNase I and KMnO 4 treatment. ( B ) KMnO 4 probing of promoter complexes formed at −20°C in 50% glycerol to prevent freezing. The 37°C controls were conducted in the presence (lanes 4 and 6) or the absence (lanes 3 and 5) of 50% glycerol in the reaction buffer. The results indicate that open complex formation and KMnO 4 sensitivity were not affected by the glycerol. See Materials and Methods for experimental details. ( C ) Quantitative KMnO 4 probing of promoter complexes formed at different temperatures. Promoter complex formation reactions were set up on ice or 37°C, brought to the assay temperature, incubated for 15 min, and probed with KMnO 4 . The reaction products were separated by denaturing PAGE ( Top ) and quantified as described in Materials and Methods ( Bottom ). KMnO 4 probing was performed at 0 (lanes 1, 12, 13, and 24); 5 (lanes 2, 11, 14, and 23); 10 (lanes 3, 10, 15, and 22); 15 (lanes 4, 9, 16, and 21); 23 (lanes 5, 8, 17, and 20); and 37°C (lanes 6, 7, 18, and 19). The upward vertical arrows indicate an up-temperature shift from 0°C to the assay temperature; downward arrows indicate a down-temperature shift from 37°C to the assay temperature.

    Techniques Used: Mutagenesis, Footprinting, Incubation, Polyacrylamide Gel Electrophoresis

    The mutant RNAP forms stable promoter complexes that lack protein–DNA contacts downstream of the transcription initiation start point. ( A ) 100 nM of a 106-bp DNA fragment containing the T7 A2 promoter (−84 to +32) 32 P-end-labeled on the bottom strand was combined with 200 nM wt or mutant RNAP in 20-μl reactions containing 40 mM Tris⋅HCl (pH 7.9), 40 mM KCl, and 10 mM MgCl 2 . Reactions were preincubated for 15 min at 37°C and footprinted with DNase I or probed with KMnO 4 . Reaction products were resolved on a 6% sequencing gel and visualized by autoradiography. ( B ) Summary of the RNAP–DNA footprinting experiments on the top and bottom strands of the T7 A2 promoter. Reactive thymines are indicated by arrows. DNase I-protected and KMnO 4 -sensitive sites found in the mutant and the wt promoter complexes are shown in black. DNase I-protected and KMnO 4 -sensitive sites specific for the wt complex are shown in gray. ( C ) Heparin resistance of RNAP-T7 A2 promoter complexes. Promoter complexes were formed as described above, and heparin was added to the final concentration 200 μg/ml (time 0), and incubation at 37°C was continued. At various time points, reaction aliquots were withdrawn, probed with KMnO 4 , resolved by denaturing PAGE, and quantified by using a PhosphorImager (Molecular Dynamics). The mean values of three independent measurements are given. The error bars represent the SD of the measurements. The normalized opening (%) value was calculated as described in Materials and Methods . ( D ) Reactions were set up as described above in a buffer containing the indicated concentrations of NaCl. Reactions were incubated for 15 min at 37°C and analyzed as in C .
    Figure Legend Snippet: The mutant RNAP forms stable promoter complexes that lack protein–DNA contacts downstream of the transcription initiation start point. ( A ) 100 nM of a 106-bp DNA fragment containing the T7 A2 promoter (−84 to +32) 32 P-end-labeled on the bottom strand was combined with 200 nM wt or mutant RNAP in 20-μl reactions containing 40 mM Tris⋅HCl (pH 7.9), 40 mM KCl, and 10 mM MgCl 2 . Reactions were preincubated for 15 min at 37°C and footprinted with DNase I or probed with KMnO 4 . Reaction products were resolved on a 6% sequencing gel and visualized by autoradiography. ( B ) Summary of the RNAP–DNA footprinting experiments on the top and bottom strands of the T7 A2 promoter. Reactive thymines are indicated by arrows. DNase I-protected and KMnO 4 -sensitive sites found in the mutant and the wt promoter complexes are shown in black. DNase I-protected and KMnO 4 -sensitive sites specific for the wt complex are shown in gray. ( C ) Heparin resistance of RNAP-T7 A2 promoter complexes. Promoter complexes were formed as described above, and heparin was added to the final concentration 200 μg/ml (time 0), and incubation at 37°C was continued. At various time points, reaction aliquots were withdrawn, probed with KMnO 4 , resolved by denaturing PAGE, and quantified by using a PhosphorImager (Molecular Dynamics). The mean values of three independent measurements are given. The error bars represent the SD of the measurements. The normalized opening (%) value was calculated as described in Materials and Methods . ( D ) Reactions were set up as described above in a buffer containing the indicated concentrations of NaCl. Reactions were incubated for 15 min at 37°C and analyzed as in C .

    Techniques Used: Mutagenesis, Labeling, Sequencing, Autoradiography, DNA Footprinting, Concentration Assay, Incubation, Polyacrylamide Gel Electrophoresis

    4) Product Images from "A mutant RNA polymerase that forms unusual open promoter complexes"

    Article Title: A mutant RNA polymerase that forms unusual open promoter complexes

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    doi:

    The mutant RNAP promoter complexes are stable at low temperatures. ( A ) DNase I footprinting and KMnO 4 probing of promoter complexes at different temperatures (bottom strand). Promoter complexes were formed at the indicated temperatures and followed by DNase I and KMnO 4 treatment. ( B ) KMnO 4 probing of promoter complexes formed at −20°C in 50% glycerol to prevent freezing. The 37°C controls were conducted in the presence (lanes 4 and 6) or the absence (lanes 3 and 5) of 50% glycerol in the reaction buffer. The results indicate that open complex formation and KMnO 4 sensitivity were not affected by the glycerol. See Materials and Methods for experimental details. ( C ) Quantitative KMnO 4 probing of promoter complexes formed at different temperatures. Promoter complex formation reactions were set up on ice or 37°C, brought to the assay temperature, incubated for 15 min, and probed with KMnO 4 . The reaction products were separated by denaturing PAGE ( Top ) and quantified as described in Materials and Methods ( Bottom ). KMnO 4 probing was performed at 0 (lanes 1, 12, 13, and 24); 5 (lanes 2, 11, 14, and 23); 10 (lanes 3, 10, 15, and 22); 15 (lanes 4, 9, 16, and 21); 23 (lanes 5, 8, 17, and 20); and 37°C (lanes 6, 7, 18, and 19). The upward vertical arrows indicate an up-temperature shift from 0°C to the assay temperature; downward arrows indicate a down-temperature shift from 37°C to the assay temperature.
    Figure Legend Snippet: The mutant RNAP promoter complexes are stable at low temperatures. ( A ) DNase I footprinting and KMnO 4 probing of promoter complexes at different temperatures (bottom strand). Promoter complexes were formed at the indicated temperatures and followed by DNase I and KMnO 4 treatment. ( B ) KMnO 4 probing of promoter complexes formed at −20°C in 50% glycerol to prevent freezing. The 37°C controls were conducted in the presence (lanes 4 and 6) or the absence (lanes 3 and 5) of 50% glycerol in the reaction buffer. The results indicate that open complex formation and KMnO 4 sensitivity were not affected by the glycerol. See Materials and Methods for experimental details. ( C ) Quantitative KMnO 4 probing of promoter complexes formed at different temperatures. Promoter complex formation reactions were set up on ice or 37°C, brought to the assay temperature, incubated for 15 min, and probed with KMnO 4 . The reaction products were separated by denaturing PAGE ( Top ) and quantified as described in Materials and Methods ( Bottom ). KMnO 4 probing was performed at 0 (lanes 1, 12, 13, and 24); 5 (lanes 2, 11, 14, and 23); 10 (lanes 3, 10, 15, and 22); 15 (lanes 4, 9, 16, and 21); 23 (lanes 5, 8, 17, and 20); and 37°C (lanes 6, 7, 18, and 19). The upward vertical arrows indicate an up-temperature shift from 0°C to the assay temperature; downward arrows indicate a down-temperature shift from 37°C to the assay temperature.

    Techniques Used: Mutagenesis, Footprinting, Incubation, Polyacrylamide Gel Electrophoresis

    The mutant RNAP forms stable promoter complexes that lack protein–DNA contacts downstream of the transcription initiation start point. ( A ) 100 nM of a 106-bp DNA fragment containing the T7 A2 promoter (−84 to +32) 32 P-end-labeled on the bottom strand was combined with 200 nM wt or mutant RNAP in 20-μl reactions containing 40 mM Tris⋅HCl (pH 7.9), 40 mM KCl, and 10 mM MgCl 2 . Reactions were preincubated for 15 min at 37°C and footprinted with DNase I or probed with KMnO 4 . Reaction products were resolved on a 6% sequencing gel and visualized by autoradiography. ( B ) Summary of the RNAP–DNA footprinting experiments on the top and bottom strands of the T7 A2 promoter. Reactive thymines are indicated by arrows. DNase I-protected and KMnO 4 -sensitive sites found in the mutant and the wt promoter complexes are shown in black. DNase I-protected and KMnO 4 -sensitive sites specific for the wt complex are shown in gray. ( C ) Heparin resistance of RNAP-T7 A2 promoter complexes. Promoter complexes were formed as described above, and heparin was added to the final concentration 200 μg/ml (time 0), and incubation at 37°C was continued. At various time points, reaction aliquots were withdrawn, probed with KMnO 4 , resolved by denaturing PAGE, and quantified by using a PhosphorImager (Molecular Dynamics). The mean values of three independent measurements are given. The error bars represent the SD of the measurements. The normalized opening (%) value was calculated as described in Materials and Methods . ( D ) Reactions were set up as described above in a buffer containing the indicated concentrations of NaCl. Reactions were incubated for 15 min at 37°C and analyzed as in C .
    Figure Legend Snippet: The mutant RNAP forms stable promoter complexes that lack protein–DNA contacts downstream of the transcription initiation start point. ( A ) 100 nM of a 106-bp DNA fragment containing the T7 A2 promoter (−84 to +32) 32 P-end-labeled on the bottom strand was combined with 200 nM wt or mutant RNAP in 20-μl reactions containing 40 mM Tris⋅HCl (pH 7.9), 40 mM KCl, and 10 mM MgCl 2 . Reactions were preincubated for 15 min at 37°C and footprinted with DNase I or probed with KMnO 4 . Reaction products were resolved on a 6% sequencing gel and visualized by autoradiography. ( B ) Summary of the RNAP–DNA footprinting experiments on the top and bottom strands of the T7 A2 promoter. Reactive thymines are indicated by arrows. DNase I-protected and KMnO 4 -sensitive sites found in the mutant and the wt promoter complexes are shown in black. DNase I-protected and KMnO 4 -sensitive sites specific for the wt complex are shown in gray. ( C ) Heparin resistance of RNAP-T7 A2 promoter complexes. Promoter complexes were formed as described above, and heparin was added to the final concentration 200 μg/ml (time 0), and incubation at 37°C was continued. At various time points, reaction aliquots were withdrawn, probed with KMnO 4 , resolved by denaturing PAGE, and quantified by using a PhosphorImager (Molecular Dynamics). The mean values of three independent measurements are given. The error bars represent the SD of the measurements. The normalized opening (%) value was calculated as described in Materials and Methods . ( D ) Reactions were set up as described above in a buffer containing the indicated concentrations of NaCl. Reactions were incubated for 15 min at 37°C and analyzed as in C .

    Techniques Used: Mutagenesis, Labeling, Sequencing, Autoradiography, DNA Footprinting, Concentration Assay, Incubation, Polyacrylamide Gel Electrophoresis

    Related Articles

    In Vivo:

    Article Title: Nucleosomes Are Translationally Positioned on the Active Allele and Rotationally Positioned on the Inactive Allele of the HPRT Promoter
    Article Snippet: .. In vivo DNase I footprint analysis was performed by treating permeabilized 4.12 and 8121 cells with increasing concentrations of DNase I, purifying the DNase I-treated genomic DNA, and examining the DNase I cleavage pattern in the region of interest by LMPCR. ..

    Concentration Assay:

    Article Title: A Cellular Protein Binds Vaccinia Virus Late Promoters and Activates Transcription In Vitro
    Article Snippet: .. DNase I (Worthington Biochemicals) was added to a concentration of 8 ng/ml, and incubation was continued for an additional 2 min, after which the cleavage reaction was terminated by addition of an equal volume of a stop solution (0.2 M NaCl, 30 mM EDTA, 1% sodium dodecyl sulfate, and 100 μg of glycogen/ml). .. DNA cleavage products were extracted with phenol-chloroform, precipitated with ethanol, and analyzed on a 6% polyacrylamide DNA sequencing gel.

    Incubation:

    Article Title: A Cellular Protein Binds Vaccinia Virus Late Promoters and Activates Transcription In Vitro
    Article Snippet: .. DNase I (Worthington Biochemicals) was added to a concentration of 8 ng/ml, and incubation was continued for an additional 2 min, after which the cleavage reaction was terminated by addition of an equal volume of a stop solution (0.2 M NaCl, 30 mM EDTA, 1% sodium dodecyl sulfate, and 100 μg of glycogen/ml). .. DNA cleavage products were extracted with phenol-chloroform, precipitated with ethanol, and analyzed on a 6% polyacrylamide DNA sequencing gel.

    other:

    Article Title: Structural and functional conservation at the boundaries of the chicken ?-globin domain
    Article Snippet: The DNase I HS, 3′HS, was detected by digestion of nuclei with increasing amounts of DNase I as above followed by digestion of extracted DNA with Kpn I and probing with i112 (1000 bp; Kpn I –Pst I at 23.3–24.3 map units).

    Article Title: Structural and functional conservation at the boundaries of the chicken ?-globin domain
    Article Snippet: [ ] [ ] Stalder J., Larsen,A., Engel,J.D., Dolan,M., Groudine,M. and Weintraub,H. (1980) Tissue-specific DNA cleavages in the globin chromatin domain introduced by DNase I.

    Activity Assay:

    Article Title: Dynamic BRG1 Recruitment during T Helper Differentiation and Activation Reveals Distal Regulatory Elements ▿Dynamic BRG1 Recruitment during T Helper Differentiation and Activation Reveals Distal Regulatory Elements ▿ §
    Article Snippet: .. Newly identified distal BRG1 binding regions in the GATA3 locus were specific with respect to fate and hypersensitive to DNase I and possessed BRG1-dependent enhancer-like activity. .. BRG1 binding to these regions was dependent on the presence of STAT6.

    Sequencing:

    Article Title: Role of the Promoter in Maintaining Transcriptionally Active Chromatin Structure and DNA Methylation Patterns In Vivo
    Article Snippet: .. It is possible that the steeper slope detected by this probe is indicative of an intrinsically higher accessibility of the 5′flanking region to DNase I (or preferential DNase I cleavage of the underlying DNA sequence). ..

    Staining:

    Article Title: Constitutive Nucleosome Depletion and Ordered Factor Assembly at the GRP78 Promoter Revealed by Single Molecule Footprinting
    Article Snippet: .. These were then digested at 37 °C for 15 min using various concentrations of DNase I (Worthington, San Francisco, California, United States) to obtain a suitable range of digestion of genomic DNA as revealed by EtBr staining. .. Digested genomic DNA was purified, redigested by RsaI, resolved on a 1.5% agarose gel, and Southern blotted.

    Binding Assay:

    Article Title: Dynamic BRG1 Recruitment during T Helper Differentiation and Activation Reveals Distal Regulatory Elements ▿Dynamic BRG1 Recruitment during T Helper Differentiation and Activation Reveals Distal Regulatory Elements ▿ §
    Article Snippet: .. Newly identified distal BRG1 binding regions in the GATA3 locus were specific with respect to fate and hypersensitive to DNase I and possessed BRG1-dependent enhancer-like activity. .. BRG1 binding to these regions was dependent on the presence of STAT6.

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • trar  (Worthington Biochemical)
    90
    Worthington Biochemical trar
    Models for <t>TraR</t> and the TraR–RNAP complex. ( A ) RaptorX-derived model for TraR. N- and C-termini are indicated, the four cysteine residues (C4) are tan spheres, and residues D3, D6, A8, I20, and E66 are in blue stick form. ( B ) TraR (blue) and <t>DksA</t> (green) were positioned manually based on alignment of TraR D3, D6, and A8 with DksA D71, D74, and A76, a portion of the TraR N-terminal α-helix, and the DksA α-helix 2 in its coiled-coil. Cysteines (C4) are yellow or tan spheres. ( C ) Model for TraR binding to E. coli ). The square corresponds to the area of the complex shown in expanded form in D and E . TraR is dark blue; the RNAP β-subunit is cyan, β′ is pink, the β′ secondary channel rim is yellow, and ω is pale blue. β′ Residues N680, K681A, and E677 are shown as orange spheres. ppGpp at site 1 is shown in red. TraR residues D3, D6, I44, A47, R48, I51, A47, and E66 are shown as blue spheres. ( D ) Enlarged view of TraR bound to RNAP secondary channel, as in C . I20 is in stick form. BH, bridge helix. ( E .
    Trar, supplied by Worthington Biochemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trar/product/Worthington Biochemical
    Average 90 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    trar - by Bioz Stars, 2021-01
    90/100 stars
    		  Buy from Supplier
    dksa  (Worthington Biochemical)
    90
    Worthington Biochemical dksa
    Models for <t>TraR</t> and the TraR–RNAP complex. ( A ) RaptorX-derived model for TraR. N- and C-termini are indicated, the four cysteine residues (C4) are tan spheres, and residues D3, D6, A8, I20, and E66 are in blue stick form. ( B ) TraR (blue) and <t>DksA</t> (green) were positioned manually based on alignment of TraR D3, D6, and A8 with DksA D71, D74, and A76, a portion of the TraR N-terminal α-helix, and the DksA α-helix 2 in its coiled-coil. Cysteines (C4) are yellow or tan spheres. ( C ) Model for TraR binding to E. coli ). The square corresponds to the area of the complex shown in expanded form in D and E . TraR is dark blue; the RNAP β-subunit is cyan, β′ is pink, the β′ secondary channel rim is yellow, and ω is pale blue. β′ Residues N680, K681A, and E677 are shown as orange spheres. ppGpp at site 1 is shown in red. TraR residues D3, D6, I44, A47, R48, I51, A47, and E66 are shown as blue spheres. ( D ) Enlarged view of TraR bound to RNAP secondary channel, as in C . I20 is in stick form. BH, bridge helix. ( E .
    Dksa, supplied by Worthington Biochemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dksa/product/Worthington Biochemical
    Average 90 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    dksa - by Bioz Stars, 2021-01
    90/100 stars
    		  Buy from Supplier
    kcl  (Worthington Biochemical)
    92
    Worthington Biochemical kcl
    Models for <t>TraR</t> and the TraR–RNAP complex. ( A ) RaptorX-derived model for TraR. N- and C-termini are indicated, the four cysteine residues (C4) are tan spheres, and residues D3, D6, A8, I20, and E66 are in blue stick form. ( B ) TraR (blue) and <t>DksA</t> (green) were positioned manually based on alignment of TraR D3, D6, and A8 with DksA D71, D74, and A76, a portion of the TraR N-terminal α-helix, and the DksA α-helix 2 in its coiled-coil. Cysteines (C4) are yellow or tan spheres. ( C ) Model for TraR binding to E. coli ). The square corresponds to the area of the complex shown in expanded form in D and E . TraR is dark blue; the RNAP β-subunit is cyan, β′ is pink, the β′ secondary channel rim is yellow, and ω is pale blue. β′ Residues N680, K681A, and E677 are shown as orange spheres. ppGpp at site 1 is shown in red. TraR residues D3, D6, I44, A47, R48, I51, A47, and E66 are shown as blue spheres. ( D ) Enlarged view of TraR bound to RNAP secondary channel, as in C . I20 is in stick form. BH, bridge helix. ( E .
    Kcl, supplied by Worthington Biochemical, used in various techniques. Bioz Stars score: 92/100, based on 86 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/kcl/product/Worthington Biochemical
    Average 92 stars, based on 86 article reviews
    Price from $9.99 to $1999.99
    kcl - by Bioz Stars, 2021-01
    92/100 stars
    		  Buy from Supplier
    bsa  (Worthington Biochemical)
    92
    Worthington Biochemical bsa
    Models for <t>TraR</t> and the TraR–RNAP complex. ( A ) RaptorX-derived model for TraR. N- and C-termini are indicated, the four cysteine residues (C4) are tan spheres, and residues D3, D6, A8, I20, and E66 are in blue stick form. ( B ) TraR (blue) and <t>DksA</t> (green) were positioned manually based on alignment of TraR D3, D6, and A8 with DksA D71, D74, and A76, a portion of the TraR N-terminal α-helix, and the DksA α-helix 2 in its coiled-coil. Cysteines (C4) are yellow or tan spheres. ( C ) Model for TraR binding to E. coli ). The square corresponds to the area of the complex shown in expanded form in D and E . TraR is dark blue; the RNAP β-subunit is cyan, β′ is pink, the β′ secondary channel rim is yellow, and ω is pale blue. β′ Residues N680, K681A, and E677 are shown as orange spheres. ppGpp at site 1 is shown in red. TraR residues D3, D6, I44, A47, R48, I51, A47, and E66 are shown as blue spheres. ( D ) Enlarged view of TraR bound to RNAP secondary channel, as in C . I20 is in stick form. BH, bridge helix. ( E .
    Bsa, supplied by Worthington Biochemical, used in various techniques. Bioz Stars score: 92/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bsa/product/Worthington Biochemical
    Average 92 stars, based on 2 article reviews
    Price from $9.99 to $1999.99
    bsa - by Bioz Stars, 2021-01
    92/100 stars
    		  Buy from Supplier

    Image Search Results


    Models for TraR and the TraR–RNAP complex. ( A ) RaptorX-derived model for TraR. N- and C-termini are indicated, the four cysteine residues (C4) are tan spheres, and residues D3, D6, A8, I20, and E66 are in blue stick form. ( B ) TraR (blue) and DksA (green) were positioned manually based on alignment of TraR D3, D6, and A8 with DksA D71, D74, and A76, a portion of the TraR N-terminal α-helix, and the DksA α-helix 2 in its coiled-coil. Cysteines (C4) are yellow or tan spheres. ( C ) Model for TraR binding to E. coli ). The square corresponds to the area of the complex shown in expanded form in D and E . TraR is dark blue; the RNAP β-subunit is cyan, β′ is pink, the β′ secondary channel rim is yellow, and ω is pale blue. β′ Residues N680, K681A, and E677 are shown as orange spheres. ppGpp at site 1 is shown in red. TraR residues D3, D6, I44, A47, R48, I51, A47, and E66 are shown as blue spheres. ( D ) Enlarged view of TraR bound to RNAP secondary channel, as in C . I20 is in stick form. BH, bridge helix. ( E .

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    Article Title: TraR directly regulates transcription initiation by mimicking the combined effects of the global regulators DksA and ppGpp

    doi: 10.1073/pnas.1704105114

    Figure Lengend Snippet: Models for TraR and the TraR–RNAP complex. ( A ) RaptorX-derived model for TraR. N- and C-termini are indicated, the four cysteine residues (C4) are tan spheres, and residues D3, D6, A8, I20, and E66 are in blue stick form. ( B ) TraR (blue) and DksA (green) were positioned manually based on alignment of TraR D3, D6, and A8 with DksA D71, D74, and A76, a portion of the TraR N-terminal α-helix, and the DksA α-helix 2 in its coiled-coil. Cysteines (C4) are yellow or tan spheres. ( C ) Model for TraR binding to E. coli ). The square corresponds to the area of the complex shown in expanded form in D and E . TraR is dark blue; the RNAP β-subunit is cyan, β′ is pink, the β′ secondary channel rim is yellow, and ω is pale blue. β′ Residues N680, K681A, and E677 are shown as orange spheres. ppGpp at site 1 is shown in red. TraR residues D3, D6, I44, A47, R48, I51, A47, and E66 are shown as blue spheres. ( D ) Enlarged view of TraR bound to RNAP secondary channel, as in C . I20 is in stick form. BH, bridge helix. ( E .

    Article Snippet: For DNaseI footprinting reactions, 5 nM RNAP was added to end-labeled DNA in buffer containing 30 mM KCl, 10 mM Tris⋅Cl, pH 8.0, 10 mM MgCl2 , 1 mM DTT, 0.1 mg/mL BSA, in the presence or absence of 5 μM TraR or DksA, and incubated at 37 °C for 10 min. DNaseI (Worthington DPFF) was added to a concentration of 10 μg/mL for 30 s, and the reactions were stopped by addition of 10 mM EDTA, 0.3 M sodium acetate, and an equal volume of phenol.

    Techniques: Derivative Assay, Binding Assay

    ( A ) Activation of p hisG , p livJ , or RNA-1 by TraR (0–500 nM). ( B ) Activation shown reflects maximum activation observed. Transcription of iraP P1 is activated to a different extent by TraR vs. DksA/ppGpp. Values plotted with TraR (1 µM), DksA (1 µM), or DksA (2 µM) and ppGpp (50 µM) together, relative to transcription without factors (set to 1).

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    Article Title: TraR directly regulates transcription initiation by mimicking the combined effects of the global regulators DksA and ppGpp

    doi: 10.1073/pnas.1704105114

    Figure Lengend Snippet: ( A ) Activation of p hisG , p livJ , or RNA-1 by TraR (0–500 nM). ( B ) Activation shown reflects maximum activation observed. Transcription of iraP P1 is activated to a different extent by TraR vs. DksA/ppGpp. Values plotted with TraR (1 µM), DksA (1 µM), or DksA (2 µM) and ppGpp (50 µM) together, relative to transcription without factors (set to 1).

    Article Snippet: For DNaseI footprinting reactions, 5 nM RNAP was added to end-labeled DNA in buffer containing 30 mM KCl, 10 mM Tris⋅Cl, pH 8.0, 10 mM MgCl2 , 1 mM DTT, 0.1 mg/mL BSA, in the presence or absence of 5 μM TraR or DksA, and incubated at 37 °C for 10 min. DNaseI (Worthington DPFF) was added to a concentration of 10 μg/mL for 30 s, and the reactions were stopped by addition of 10 mM EDTA, 0.3 M sodium acetate, and an equal volume of phenol.

    Techniques: Activation Assay

    A half-DksA variant, similar in length to WT TraR, does not complement a ∆ dksA mutant. ( A ) Representative Western blot from cell lysates made from a ∆ dksA strain carrying either the WT gene or the half - dksA gene fused to an IPTG-inducible promoter. Cells were harvested 1, 2, or 3 h after induction with 0.5 mM IPTG. One-microgram of cell lysate was loaded in each lane, and purified DksA-HMK was loaded in lane 1 for comparison. Somewhat lower amounts of the half-DksA variant were observed than of WT DksA, which could be attributable to lower stability of the half-DksA variant or to reduced ability of the DksA antibody to recognize the half-DksA peptide. ( B and C ) Growth on plates containing defined medium without amino acids and ( B ) 0.1 mM IPTG or ( C ) 1 mM IPTG. Sector 1: empty vector control. Sector 2: plasmid containing half - dksA gene. Sector 3: plasmid containing the full-length traR gene. Sector 4: plasmid containing the full-length dksA gene. Even if the half-DksA concentration was lower than the WT DksA concentration, it is likely that the half-DksA would have still resulted in at least partial complementation, because we showed previously that even 50% of the WT concentration supplied from a plasmid was sufficient to complement a ∆ dksA ).

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    Article Title: TraR directly regulates transcription initiation by mimicking the combined effects of the global regulators DksA and ppGpp

    doi: 10.1073/pnas.1704105114

    Figure Lengend Snippet: A half-DksA variant, similar in length to WT TraR, does not complement a ∆ dksA mutant. ( A ) Representative Western blot from cell lysates made from a ∆ dksA strain carrying either the WT gene or the half - dksA gene fused to an IPTG-inducible promoter. Cells were harvested 1, 2, or 3 h after induction with 0.5 mM IPTG. One-microgram of cell lysate was loaded in each lane, and purified DksA-HMK was loaded in lane 1 for comparison. Somewhat lower amounts of the half-DksA variant were observed than of WT DksA, which could be attributable to lower stability of the half-DksA variant or to reduced ability of the DksA antibody to recognize the half-DksA peptide. ( B and C ) Growth on plates containing defined medium without amino acids and ( B ) 0.1 mM IPTG or ( C ) 1 mM IPTG. Sector 1: empty vector control. Sector 2: plasmid containing half - dksA gene. Sector 3: plasmid containing the full-length traR gene. Sector 4: plasmid containing the full-length dksA gene. Even if the half-DksA concentration was lower than the WT DksA concentration, it is likely that the half-DksA would have still resulted in at least partial complementation, because we showed previously that even 50% of the WT concentration supplied from a plasmid was sufficient to complement a ∆ dksA ).

    Article Snippet: For DNaseI footprinting reactions, 5 nM RNAP was added to end-labeled DNA in buffer containing 30 mM KCl, 10 mM Tris⋅Cl, pH 8.0, 10 mM MgCl2 , 1 mM DTT, 0.1 mg/mL BSA, in the presence or absence of 5 μM TraR or DksA, and incubated at 37 °C for 10 min. DNaseI (Worthington DPFF) was added to a concentration of 10 μg/mL for 30 s, and the reactions were stopped by addition of 10 mM EDTA, 0.3 M sodium acetate, and an equal volume of phenol.

    Techniques: Variant Assay, Mutagenesis, Western Blot, Purification, Plasmid Preparation, Concentration Assay

    TraR is more active than DksA for inhibition of transcription but has a similar affinity for RNAP. ( A ) Multiround in vitro transcription of rrnB P1 or lacUV 5 at a range of concentrations of TraR (wedge indicates 1 nM to 1 µM for rrnB P1 or 1 nM to 2 µM for lacUV5 ) or of DksA (wedge indicates 4 nM to 8 µM). Plasmid templates also contained the RNA-1 promoter. ( B ) Quantification of transcripts from experiments like those in A plotted relative to values in the absence of TraR or DksA. The IC 50 for inhibition by TraR was ∼50 nM and for DksA ∼1.3 µM [averages with SDs from at least three independent experiments ( n = 3)]. ( C ) Cross-linking with β′ R933-Bpa RNAP, β′ Q929-Bpa RNAP, or β′ R1148-Bpa RNAP with 32 P-TraR or 32 P-DksA. The portion of a representative 4–12% SDS gel containing the cross-linked β′-DksA or β′-TraR products is shown. ( D ) Unlabeled DksA or TraR competes similarly for binding of 32 P-labeled HMK-DksA to RNAP. Unlabeled DksA or TraR (0–16 µM) was added to 1 µM 32 P-DksA and 0.1 µM core RNAP before Fe 2+ -mediated cleavage of DksA. Fraction of 32 P-DksA cleaved was normalized to that in the absence of competitor. Next, 1 µM unlabeled DksA or 0.6 µM unlabeled TraR reduced cleavage of 1 µM 32 P-DksA by ∼50% ( n = 3). ( E ) Representative gel showing DNase I footprints of RNAP bound to the rrnB P1 promoter, 3′ end-labeled on the template strand, with or without TraR or DksA. DNase I digested fragment without RNAP or added factors (lanes 1 and 2), with RNAP alone (lanes 3 and 4), with RNAP + 5 µM DksA (lanes 5 and 6), or with RNAP and 5 µM TraR (lanes 7 and 8). Undigested fragment (lane 9). A+G sequence ladder is on the Left . Traces of gel lanes showing extent of protection are on the Right . Colored dots indicate the downstream boundary of DNase I protection without (green dot; ∼+12), or with (red or blue dots; ∼+1) DksA or TraR. The upstream boundary of protection in lanes 3–8 is ∼−59 ( n = 3). ( F ) TraR and DksA alter the lifetime of rrnB P1(dis) promoter complexes in vitro. RNAP–promoter complexes were preformed with TraR (15 nM) or DksA (15 nM or 500 nM), or without factors, and the fraction remaining at the indicated times after heparin addition was determined by transcription. Half-lives of rrnB P1(dis) complexes: no added factor, 18 min; 15 nM TraR, 3 min; 15 nM DksA, 18 min; 500 nM DksA, 6 min. Error bars indicate the range from two independent experiments ( n = 2).

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    Article Title: TraR directly regulates transcription initiation by mimicking the combined effects of the global regulators DksA and ppGpp

    doi: 10.1073/pnas.1704105114

    Figure Lengend Snippet: TraR is more active than DksA for inhibition of transcription but has a similar affinity for RNAP. ( A ) Multiround in vitro transcription of rrnB P1 or lacUV 5 at a range of concentrations of TraR (wedge indicates 1 nM to 1 µM for rrnB P1 or 1 nM to 2 µM for lacUV5 ) or of DksA (wedge indicates 4 nM to 8 µM). Plasmid templates also contained the RNA-1 promoter. ( B ) Quantification of transcripts from experiments like those in A plotted relative to values in the absence of TraR or DksA. The IC 50 for inhibition by TraR was ∼50 nM and for DksA ∼1.3 µM [averages with SDs from at least three independent experiments ( n = 3)]. ( C ) Cross-linking with β′ R933-Bpa RNAP, β′ Q929-Bpa RNAP, or β′ R1148-Bpa RNAP with 32 P-TraR or 32 P-DksA. The portion of a representative 4–12% SDS gel containing the cross-linked β′-DksA or β′-TraR products is shown. ( D ) Unlabeled DksA or TraR competes similarly for binding of 32 P-labeled HMK-DksA to RNAP. Unlabeled DksA or TraR (0–16 µM) was added to 1 µM 32 P-DksA and 0.1 µM core RNAP before Fe 2+ -mediated cleavage of DksA. Fraction of 32 P-DksA cleaved was normalized to that in the absence of competitor. Next, 1 µM unlabeled DksA or 0.6 µM unlabeled TraR reduced cleavage of 1 µM 32 P-DksA by ∼50% ( n = 3). ( E ) Representative gel showing DNase I footprints of RNAP bound to the rrnB P1 promoter, 3′ end-labeled on the template strand, with or without TraR or DksA. DNase I digested fragment without RNAP or added factors (lanes 1 and 2), with RNAP alone (lanes 3 and 4), with RNAP + 5 µM DksA (lanes 5 and 6), or with RNAP and 5 µM TraR (lanes 7 and 8). Undigested fragment (lane 9). A+G sequence ladder is on the Left . Traces of gel lanes showing extent of protection are on the Right . Colored dots indicate the downstream boundary of DNase I protection without (green dot; ∼+12), or with (red or blue dots; ∼+1) DksA or TraR. The upstream boundary of protection in lanes 3–8 is ∼−59 ( n = 3). ( F ) TraR and DksA alter the lifetime of rrnB P1(dis) promoter complexes in vitro. RNAP–promoter complexes were preformed with TraR (15 nM) or DksA (15 nM or 500 nM), or without factors, and the fraction remaining at the indicated times after heparin addition was determined by transcription. Half-lives of rrnB P1(dis) complexes: no added factor, 18 min; 15 nM TraR, 3 min; 15 nM DksA, 18 min; 500 nM DksA, 6 min. Error bars indicate the range from two independent experiments ( n = 2).

    Article Snippet: For DNaseI footprinting reactions, 5 nM RNAP was added to end-labeled DNA in buffer containing 30 mM KCl, 10 mM Tris⋅Cl, pH 8.0, 10 mM MgCl2 , 1 mM DTT, 0.1 mg/mL BSA, in the presence or absence of 5 μM TraR or DksA, and incubated at 37 °C for 10 min. DNaseI (Worthington DPFF) was added to a concentration of 10 μg/mL for 30 s, and the reactions were stopped by addition of 10 mM EDTA, 0.3 M sodium acetate, and an equal volume of phenol.

    Techniques: Inhibition, In Vitro, Plasmid Preparation, SDS-Gel, Binding Assay, Labeling, Sequencing

    Models for TraR and the TraR–RNAP complex. ( A ) RaptorX-derived model for TraR. N- and C-termini are indicated, the four cysteine residues (C4) are tan spheres, and residues D3, D6, A8, I20, and E66 are in blue stick form. ( B ) TraR (blue) and DksA (green) were positioned manually based on alignment of TraR D3, D6, and A8 with DksA D71, D74, and A76, a portion of the TraR N-terminal α-helix, and the DksA α-helix 2 in its coiled-coil. Cysteines (C4) are yellow or tan spheres. ( C ) Model for TraR binding to E. coli ). The square corresponds to the area of the complex shown in expanded form in D and E . TraR is dark blue; the RNAP β-subunit is cyan, β′ is pink, the β′ secondary channel rim is yellow, and ω is pale blue. β′ Residues N680, K681A, and E677 are shown as orange spheres. ppGpp at site 1 is shown in red. TraR residues D3, D6, I44, A47, R48, I51, A47, and E66 are shown as blue spheres. ( D ) Enlarged view of TraR bound to RNAP secondary channel, as in C . I20 is in stick form. BH, bridge helix. ( E .

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    Article Title: TraR directly regulates transcription initiation by mimicking the combined effects of the global regulators DksA and ppGpp

    doi: 10.1073/pnas.1704105114

    Figure Lengend Snippet: Models for TraR and the TraR–RNAP complex. ( A ) RaptorX-derived model for TraR. N- and C-termini are indicated, the four cysteine residues (C4) are tan spheres, and residues D3, D6, A8, I20, and E66 are in blue stick form. ( B ) TraR (blue) and DksA (green) were positioned manually based on alignment of TraR D3, D6, and A8 with DksA D71, D74, and A76, a portion of the TraR N-terminal α-helix, and the DksA α-helix 2 in its coiled-coil. Cysteines (C4) are yellow or tan spheres. ( C ) Model for TraR binding to E. coli ). The square corresponds to the area of the complex shown in expanded form in D and E . TraR is dark blue; the RNAP β-subunit is cyan, β′ is pink, the β′ secondary channel rim is yellow, and ω is pale blue. β′ Residues N680, K681A, and E677 are shown as orange spheres. ppGpp at site 1 is shown in red. TraR residues D3, D6, I44, A47, R48, I51, A47, and E66 are shown as blue spheres. ( D ) Enlarged view of TraR bound to RNAP secondary channel, as in C . I20 is in stick form. BH, bridge helix. ( E .

    Article Snippet: For DNaseI footprinting reactions, 5 nM RNAP was added to end-labeled DNA in buffer containing 30 mM KCl, 10 mM Tris⋅Cl, pH 8.0, 10 mM MgCl2 , 1 mM DTT, 0.1 mg/mL BSA, in the presence or absence of 5 μM TraR or DksA, and incubated at 37 °C for 10 min. DNaseI (Worthington DPFF) was added to a concentration of 10 μg/mL for 30 s, and the reactions were stopped by addition of 10 mM EDTA, 0.3 M sodium acetate, and an equal volume of phenol.

    Techniques: Derivative Assay, Binding Assay

    ( A ) Activation of p hisG , p livJ , or RNA-1 by TraR (0–500 nM). ( B ) Activation shown reflects maximum activation observed. Transcription of iraP P1 is activated to a different extent by TraR vs. DksA/ppGpp. Values plotted with TraR (1 µM), DksA (1 µM), or DksA (2 µM) and ppGpp (50 µM) together, relative to transcription without factors (set to 1).

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    Article Title: TraR directly regulates transcription initiation by mimicking the combined effects of the global regulators DksA and ppGpp

    doi: 10.1073/pnas.1704105114

    Figure Lengend Snippet: ( A ) Activation of p hisG , p livJ , or RNA-1 by TraR (0–500 nM). ( B ) Activation shown reflects maximum activation observed. Transcription of iraP P1 is activated to a different extent by TraR vs. DksA/ppGpp. Values plotted with TraR (1 µM), DksA (1 µM), or DksA (2 µM) and ppGpp (50 µM) together, relative to transcription without factors (set to 1).

    Article Snippet: For DNaseI footprinting reactions, 5 nM RNAP was added to end-labeled DNA in buffer containing 30 mM KCl, 10 mM Tris⋅Cl, pH 8.0, 10 mM MgCl2 , 1 mM DTT, 0.1 mg/mL BSA, in the presence or absence of 5 μM TraR or DksA, and incubated at 37 °C for 10 min. DNaseI (Worthington DPFF) was added to a concentration of 10 μg/mL for 30 s, and the reactions were stopped by addition of 10 mM EDTA, 0.3 M sodium acetate, and an equal volume of phenol.

    Techniques: Activation Assay

    A half-DksA variant, similar in length to WT TraR, does not complement a ∆ dksA mutant. ( A ) Representative Western blot from cell lysates made from a ∆ dksA strain carrying either the WT gene or the half - dksA gene fused to an IPTG-inducible promoter. Cells were harvested 1, 2, or 3 h after induction with 0.5 mM IPTG. One-microgram of cell lysate was loaded in each lane, and purified DksA-HMK was loaded in lane 1 for comparison. Somewhat lower amounts of the half-DksA variant were observed than of WT DksA, which could be attributable to lower stability of the half-DksA variant or to reduced ability of the DksA antibody to recognize the half-DksA peptide. ( B and C ) Growth on plates containing defined medium without amino acids and ( B ) 0.1 mM IPTG or ( C ) 1 mM IPTG. Sector 1: empty vector control. Sector 2: plasmid containing half - dksA gene. Sector 3: plasmid containing the full-length traR gene. Sector 4: plasmid containing the full-length dksA gene. Even if the half-DksA concentration was lower than the WT DksA concentration, it is likely that the half-DksA would have still resulted in at least partial complementation, because we showed previously that even 50% of the WT concentration supplied from a plasmid was sufficient to complement a ∆ dksA ).

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    Article Title: TraR directly regulates transcription initiation by mimicking the combined effects of the global regulators DksA and ppGpp

    doi: 10.1073/pnas.1704105114

    Figure Lengend Snippet: A half-DksA variant, similar in length to WT TraR, does not complement a ∆ dksA mutant. ( A ) Representative Western blot from cell lysates made from a ∆ dksA strain carrying either the WT gene or the half - dksA gene fused to an IPTG-inducible promoter. Cells were harvested 1, 2, or 3 h after induction with 0.5 mM IPTG. One-microgram of cell lysate was loaded in each lane, and purified DksA-HMK was loaded in lane 1 for comparison. Somewhat lower amounts of the half-DksA variant were observed than of WT DksA, which could be attributable to lower stability of the half-DksA variant or to reduced ability of the DksA antibody to recognize the half-DksA peptide. ( B and C ) Growth on plates containing defined medium without amino acids and ( B ) 0.1 mM IPTG or ( C ) 1 mM IPTG. Sector 1: empty vector control. Sector 2: plasmid containing half - dksA gene. Sector 3: plasmid containing the full-length traR gene. Sector 4: plasmid containing the full-length dksA gene. Even if the half-DksA concentration was lower than the WT DksA concentration, it is likely that the half-DksA would have still resulted in at least partial complementation, because we showed previously that even 50% of the WT concentration supplied from a plasmid was sufficient to complement a ∆ dksA ).

    Article Snippet: For DNaseI footprinting reactions, 5 nM RNAP was added to end-labeled DNA in buffer containing 30 mM KCl, 10 mM Tris⋅Cl, pH 8.0, 10 mM MgCl2 , 1 mM DTT, 0.1 mg/mL BSA, in the presence or absence of 5 μM TraR or DksA, and incubated at 37 °C for 10 min. DNaseI (Worthington DPFF) was added to a concentration of 10 μg/mL for 30 s, and the reactions were stopped by addition of 10 mM EDTA, 0.3 M sodium acetate, and an equal volume of phenol.

    Techniques: Variant Assay, Mutagenesis, Western Blot, Purification, Plasmid Preparation, Concentration Assay

    TraR is more active than DksA for inhibition of transcription but has a similar affinity for RNAP. ( A ) Multiround in vitro transcription of rrnB P1 or lacUV 5 at a range of concentrations of TraR (wedge indicates 1 nM to 1 µM for rrnB P1 or 1 nM to 2 µM for lacUV5 ) or of DksA (wedge indicates 4 nM to 8 µM). Plasmid templates also contained the RNA-1 promoter. ( B ) Quantification of transcripts from experiments like those in A plotted relative to values in the absence of TraR or DksA. The IC 50 for inhibition by TraR was ∼50 nM and for DksA ∼1.3 µM [averages with SDs from at least three independent experiments ( n = 3)]. ( C ) Cross-linking with β′ R933-Bpa RNAP, β′ Q929-Bpa RNAP, or β′ R1148-Bpa RNAP with 32 P-TraR or 32 P-DksA. The portion of a representative 4–12% SDS gel containing the cross-linked β′-DksA or β′-TraR products is shown. ( D ) Unlabeled DksA or TraR competes similarly for binding of 32 P-labeled HMK-DksA to RNAP. Unlabeled DksA or TraR (0–16 µM) was added to 1 µM 32 P-DksA and 0.1 µM core RNAP before Fe 2+ -mediated cleavage of DksA. Fraction of 32 P-DksA cleaved was normalized to that in the absence of competitor. Next, 1 µM unlabeled DksA or 0.6 µM unlabeled TraR reduced cleavage of 1 µM 32 P-DksA by ∼50% ( n = 3). ( E ) Representative gel showing DNase I footprints of RNAP bound to the rrnB P1 promoter, 3′ end-labeled on the template strand, with or without TraR or DksA. DNase I digested fragment without RNAP or added factors (lanes 1 and 2), with RNAP alone (lanes 3 and 4), with RNAP + 5 µM DksA (lanes 5 and 6), or with RNAP and 5 µM TraR (lanes 7 and 8). Undigested fragment (lane 9). A+G sequence ladder is on the Left . Traces of gel lanes showing extent of protection are on the Right . Colored dots indicate the downstream boundary of DNase I protection without (green dot; ∼+12), or with (red or blue dots; ∼+1) DksA or TraR. The upstream boundary of protection in lanes 3–8 is ∼−59 ( n = 3). ( F ) TraR and DksA alter the lifetime of rrnB P1(dis) promoter complexes in vitro. RNAP–promoter complexes were preformed with TraR (15 nM) or DksA (15 nM or 500 nM), or without factors, and the fraction remaining at the indicated times after heparin addition was determined by transcription. Half-lives of rrnB P1(dis) complexes: no added factor, 18 min; 15 nM TraR, 3 min; 15 nM DksA, 18 min; 500 nM DksA, 6 min. Error bars indicate the range from two independent experiments ( n = 2).

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    Article Title: TraR directly regulates transcription initiation by mimicking the combined effects of the global regulators DksA and ppGpp

    doi: 10.1073/pnas.1704105114

    Figure Lengend Snippet: TraR is more active than DksA for inhibition of transcription but has a similar affinity for RNAP. ( A ) Multiround in vitro transcription of rrnB P1 or lacUV 5 at a range of concentrations of TraR (wedge indicates 1 nM to 1 µM for rrnB P1 or 1 nM to 2 µM for lacUV5 ) or of DksA (wedge indicates 4 nM to 8 µM). Plasmid templates also contained the RNA-1 promoter. ( B ) Quantification of transcripts from experiments like those in A plotted relative to values in the absence of TraR or DksA. The IC 50 for inhibition by TraR was ∼50 nM and for DksA ∼1.3 µM [averages with SDs from at least three independent experiments ( n = 3)]. ( C ) Cross-linking with β′ R933-Bpa RNAP, β′ Q929-Bpa RNAP, or β′ R1148-Bpa RNAP with 32 P-TraR or 32 P-DksA. The portion of a representative 4–12% SDS gel containing the cross-linked β′-DksA or β′-TraR products is shown. ( D ) Unlabeled DksA or TraR competes similarly for binding of 32 P-labeled HMK-DksA to RNAP. Unlabeled DksA or TraR (0–16 µM) was added to 1 µM 32 P-DksA and 0.1 µM core RNAP before Fe 2+ -mediated cleavage of DksA. Fraction of 32 P-DksA cleaved was normalized to that in the absence of competitor. Next, 1 µM unlabeled DksA or 0.6 µM unlabeled TraR reduced cleavage of 1 µM 32 P-DksA by ∼50% ( n = 3). ( E ) Representative gel showing DNase I footprints of RNAP bound to the rrnB P1 promoter, 3′ end-labeled on the template strand, with or without TraR or DksA. DNase I digested fragment without RNAP or added factors (lanes 1 and 2), with RNAP alone (lanes 3 and 4), with RNAP + 5 µM DksA (lanes 5 and 6), or with RNAP and 5 µM TraR (lanes 7 and 8). Undigested fragment (lane 9). A+G sequence ladder is on the Left . Traces of gel lanes showing extent of protection are on the Right . Colored dots indicate the downstream boundary of DNase I protection without (green dot; ∼+12), or with (red or blue dots; ∼+1) DksA or TraR. The upstream boundary of protection in lanes 3–8 is ∼−59 ( n = 3). ( F ) TraR and DksA alter the lifetime of rrnB P1(dis) promoter complexes in vitro. RNAP–promoter complexes were preformed with TraR (15 nM) or DksA (15 nM or 500 nM), or without factors, and the fraction remaining at the indicated times after heparin addition was determined by transcription. Half-lives of rrnB P1(dis) complexes: no added factor, 18 min; 15 nM TraR, 3 min; 15 nM DksA, 18 min; 500 nM DksA, 6 min. Error bars indicate the range from two independent experiments ( n = 2).

    Article Snippet: For DNaseI footprinting reactions, 5 nM RNAP was added to end-labeled DNA in buffer containing 30 mM KCl, 10 mM Tris⋅Cl, pH 8.0, 10 mM MgCl2 , 1 mM DTT, 0.1 mg/mL BSA, in the presence or absence of 5 μM TraR or DksA, and incubated at 37 °C for 10 min. DNaseI (Worthington DPFF) was added to a concentration of 10 μg/mL for 30 s, and the reactions were stopped by addition of 10 mM EDTA, 0.3 M sodium acetate, and an equal volume of phenol.

    Techniques: Inhibition, In Vitro, Plasmid Preparation, SDS-Gel, Binding Assay, Labeling, Sequencing